A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).

NCT07729371 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Adenomatous Polyposis (FAP)

Interventions

DRUG: ST316 IV
DRUG: ST316 IV

Sponsor

Sapience Therapeutics